For the first time in five years, pharma’s digital spend has increased and there seem to be strong signs of executive buy-in for multichannel programmes.
But, as we find out in this month’s cover feature, with companies making measured progress in multichannel adoption, measuring success looks to be the next big challenge in this area.
Something else that is, or should be, giving executives pause for thought is what Professor Brian D Smith terms Pharma’s Coral Reef, as he outlines how the nature of industry competition is evolving.
Today’s life sciences environment is very different from that seen in the twentieth century, with firms called upon to demonstrate a much deeper and much wider level of expertise than ever before.
The October issue PME also takes a look at market access roadblocks for rare bleeding disorders and we hear from Janssen’s Johan van Hoof about the quest to prevent diseases taking hold.
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
PME is also available to download as an app for iPhone and iPad
